Pub Date : 2024-05-04DOI: 10.1097/ju.0000000000004009
Siobhan Sutcliffe, Chloe Falke, Cynthia S Fok, James W Griffith, Bernard L Harlow, Kimberly A Kenton, Cora E Lewis, Lisa Kane Low, Jerry L Lowder, Emily S Lukacz, Alayne D Markland, Gerald McGwin, Melanie R Meister, Elizabeth R Mueller, Diane K Newman, Ratna Pakpahan, Leslie M Rickey, Todd Rockwood, Melissa A Simon, Abigail R Smith, Kyle D Rudser, Ariana L Smith
To estimate the prevalence of a wide range of lower urinary tract symptoms (LUTS) in US women, and to explore associations with bother and discussion with healthcare providers, friends, and family.
{"title":"Lower Urinary Tract Symptoms in US Women: Contemporary Prevalence Estimates from the RISE FOR HEALTH Study.","authors":"Siobhan Sutcliffe, Chloe Falke, Cynthia S Fok, James W Griffith, Bernard L Harlow, Kimberly A Kenton, Cora E Lewis, Lisa Kane Low, Jerry L Lowder, Emily S Lukacz, Alayne D Markland, Gerald McGwin, Melanie R Meister, Elizabeth R Mueller, Diane K Newman, Ratna Pakpahan, Leslie M Rickey, Todd Rockwood, Melissa A Simon, Abigail R Smith, Kyle D Rudser, Ariana L Smith","doi":"10.1097/ju.0000000000004009","DOIUrl":"https://doi.org/10.1097/ju.0000000000004009","url":null,"abstract":"To estimate the prevalence of a wide range of lower urinary tract symptoms (LUTS) in US women, and to explore associations with bother and discussion with healthcare providers, friends, and family.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"57 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140826368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-03DOI: 10.1097/ju.0000000000004013
Josephine Hirsch, N Valeska Halstead, Theresa Meyer, James T Rague, Soojin Kim, Ilina Rosoklija, Stephanie Kielb, Jill E Larson, Vineeta T Swaroop, Robin M Bowman, Earl Y Cheng, Diana K Bowen, Elizabeth B Yerkes, David I Chu
To assess associations between health-related quality of life (HRQOL), bladder-related QOL, bladder symptoms, and bladder catheterization route among adolescents and young adults (AYA) with spina bifida (SB).
{"title":"Quality of Life and Bladder Symptoms in Adolescents and Young Adults With Spina Bifida Who Catheterize via Urethra Versus Catheterizable Channel.","authors":"Josephine Hirsch, N Valeska Halstead, Theresa Meyer, James T Rague, Soojin Kim, Ilina Rosoklija, Stephanie Kielb, Jill E Larson, Vineeta T Swaroop, Robin M Bowman, Earl Y Cheng, Diana K Bowen, Elizabeth B Yerkes, David I Chu","doi":"10.1097/ju.0000000000004013","DOIUrl":"https://doi.org/10.1097/ju.0000000000004013","url":null,"abstract":"To assess associations between health-related quality of life (HRQOL), bladder-related QOL, bladder symptoms, and bladder catheterization route among adolescents and young adults (AYA) with spina bifida (SB).","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140821824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-03DOI: 10.1097/ju.0000000000003991
Yair Lotan, Siamak Daneshmand, Neal Shore, Peter Black, Kristen R Scarpato, Amit Patel, Tony Lough, Daniel A Shoskes, Jay D Raman
AUA guidelines for patients with microhematuria (≥3 red blood cells [RBC]/high-power field [hpf]) include cystoscopy for most over age 40 due to risk of urothelial cancer (UC). Cxbladder Triage (CxbT) is a urinary genomic test with UC negative predictive value of 99%. In this prospective randomized controlled trial, we compared cystoscopy use in a standard of care (SOC) arm vs a marker-based approach.
{"title":"A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria. The Safe Testing of Risk for Asymptomatic Microhematuria Trial.","authors":"Yair Lotan, Siamak Daneshmand, Neal Shore, Peter Black, Kristen R Scarpato, Amit Patel, Tony Lough, Daniel A Shoskes, Jay D Raman","doi":"10.1097/ju.0000000000003991","DOIUrl":"https://doi.org/10.1097/ju.0000000000003991","url":null,"abstract":"AUA guidelines for patients with microhematuria (≥3 red blood cells [RBC]/high-power field [hpf]) include cystoscopy for most over age 40 due to risk of urothelial cancer (UC). Cxbladder Triage (CxbT) is a urinary genomic test with UC negative predictive value of 99%. In this prospective randomized controlled trial, we compared cystoscopy use in a standard of care (SOC) arm vs a marker-based approach.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"140 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140821539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-03DOI: 10.1097/ju.0000000000003979
Badar M Mian, Paul J Feustel, Asef Aziz, Ronald P Kaufman, Adrien Bernstein, Hugh A G Fisher
The comparative effectiveness of transrectal and transperineal prostate biopsy in detecting clinically significant prostate cancer is not well understood. We conducted a randomized clinical trial to determine whether transperineal biopsy improves the detection of clinically significant prostate cancer.
{"title":"Clinically Significant Prostate Cancer Detection Following Transrectal and Transperineal Biopsy: Results of the Prostate Biopsy Efficacy and Complications Randomized Clinical Trial.","authors":"Badar M Mian, Paul J Feustel, Asef Aziz, Ronald P Kaufman, Adrien Bernstein, Hugh A G Fisher","doi":"10.1097/ju.0000000000003979","DOIUrl":"https://doi.org/10.1097/ju.0000000000003979","url":null,"abstract":"The comparative effectiveness of transrectal and transperineal prostate biopsy in detecting clinically significant prostate cancer is not well understood. We conducted a randomized clinical trial to determine whether transperineal biopsy improves the detection of clinically significant prostate cancer.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140821825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-26DOI: 10.1097/JU.0000000000003917
David S Wang
{"title":"Office Urology, Perioperative Care, Urinary Diversions.","authors":"David S Wang","doi":"10.1097/JU.0000000000003917","DOIUrl":"https://doi.org/10.1097/JU.0000000000003917","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"11 46","pages":"101097JU0000000000003917"},"PeriodicalIF":0.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140652493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-25DOI: 10.1097/JU.0000000000003916
J. Q. Clemens
{"title":"Infection and Inflammation of the Genitourinary Tract.","authors":"J. Q. Clemens","doi":"10.1097/JU.0000000000003916","DOIUrl":"https://doi.org/10.1097/JU.0000000000003916","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"7 10","pages":"101097JU0000000000003916"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140654254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-25DOI: 10.1097/JU.0000000000003956
N. Bhojani, Daniel Wollin, M. E. El Tayeb, K. Scotland, J. Knoedler, Karen L. Stern, David-Dan Nguyen, Marcelino Rivera, Michael S Borofsky, N. Canvasser, S. Bechis, Ryan S. Hsi
{"title":"Reply: Prospective Multicenter Evaluation of Pain Before and After Removal of Nonobstructing Renal Calculi: A CoRE Initiative.","authors":"N. Bhojani, Daniel Wollin, M. E. El Tayeb, K. Scotland, J. Knoedler, Karen L. Stern, David-Dan Nguyen, Marcelino Rivera, Michael S Borofsky, N. Canvasser, S. Bechis, Ryan S. Hsi","doi":"10.1097/JU.0000000000003956","DOIUrl":"https://doi.org/10.1097/JU.0000000000003956","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"6 4","pages":"101097JU0000000000003956"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140654025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-25DOI: 10.1097/JU.0000000000003981
Jeffrey Holzbeierlein, B. Bixler, David I Buckley, Sam S Chang, Rebecca S Holmes, Andrew C James, Erin Kirkby, James M. McKiernan, A. Schuckman
PURPOSE Although representing approximately 25% of patients diagnosed with bladder cancer, muscle-invasive bladder cancer (MIBC) carries a significant risk of death that has not significantly changed in decades. Increasingly, clinicians and patients recognize the importance of multidisciplinary collaborative efforts that take into account survival and quality of life concerns. This guideline provides a risk-stratified, clinical framework for the management of muscle-invasive urothelial bladder cancer. METHODOLOGY/METHODS In 2024, the MIBC guideline was updated through the AUA amendment process in which newly published literature is reviewed and integrated into previously published guidelines in an effort to maintain currency. The amendment allowed for the incorporation of additional literature released since the previous 2020 amendment. The updated search gathered literature from May 2020 to November 2023. This review identified 3739 abstracts, of which 46 met inclusion criteria.When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinions. RESULTS Updates were made regarding neoadjuvant/adjuvant chemotherapy, radical cystectomy, pelvic lymphadenectomy, multi-modal bladder preserving therapy, and future directions. Further revisions were made to the methodology and reference sections as appropriate. CONCLUSIONS This guideline seeks to improve clinicians' ability to evaluate and treat patients with MIBC based on currently available evidence. Future studies will be essential to further support or refine these statements to improve patient care.
{"title":"Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024).","authors":"Jeffrey Holzbeierlein, B. Bixler, David I Buckley, Sam S Chang, Rebecca S Holmes, Andrew C James, Erin Kirkby, James M. McKiernan, A. Schuckman","doi":"10.1097/JU.0000000000003981","DOIUrl":"https://doi.org/10.1097/JU.0000000000003981","url":null,"abstract":"PURPOSE\u0000Although representing approximately 25% of patients diagnosed with bladder cancer, muscle-invasive bladder cancer (MIBC) carries a significant risk of death that has not significantly changed in decades. Increasingly, clinicians and patients recognize the importance of multidisciplinary collaborative efforts that take into account survival and quality of life concerns. This guideline provides a risk-stratified, clinical framework for the management of muscle-invasive urothelial bladder cancer.\u0000\u0000\u0000METHODOLOGY/METHODS\u0000In 2024, the MIBC guideline was updated through the AUA amendment process in which newly published literature is reviewed and integrated into previously published guidelines in an effort to maintain currency. The amendment allowed for the incorporation of additional literature released since the previous 2020 amendment. The updated search gathered literature from May 2020 to November 2023. This review identified 3739 abstracts, of which 46 met inclusion criteria.When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinions.\u0000\u0000\u0000RESULTS\u0000Updates were made regarding neoadjuvant/adjuvant chemotherapy, radical cystectomy, pelvic lymphadenectomy, multi-modal bladder preserving therapy, and future directions. Further revisions were made to the methodology and reference sections as appropriate.\u0000\u0000\u0000CONCLUSIONS\u0000This guideline seeks to improve clinicians' ability to evaluate and treat patients with MIBC based on currently available evidence. Future studies will be essential to further support or refine these statements to improve patient care.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"34 34","pages":"101097JU0000000000003981"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140657523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-24DOI: 10.1097/JU.0000000000003937
Cathee Till, P. Goodman, C. Tangen, M. S. Lucia, Ian M. Thompson
{"title":"Letter: Survival After Selenium and Vitamin E Supplementation: Long-Term Followup of the Selenium and Vitamin E Cancer Prevention Trial.","authors":"Cathee Till, P. Goodman, C. Tangen, M. S. Lucia, Ian M. Thompson","doi":"10.1097/JU.0000000000003937","DOIUrl":"https://doi.org/10.1097/JU.0000000000003937","url":null,"abstract":"","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"60 10","pages":"101097JU0000000000003937"},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140662807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：